Conquer Cancer–Israel Cancer Research Fund Career Development Award

    From Conquer Cancer Fdn Of The American Society Of Clinical Oncology

    Accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer.

    Type of Support

    Overview

    The Conquer Cancer – Israel Cancer Research Fund (ICRF) Career Development Award (CDA) targets early-career Israeli clinical investigators who have recently received their initial faculty appointments. The goal is to enable these professionals to establish independent clinical cancer research programs in Israel. The grant supports all oncology subspecialties, emphasizing the development of clinical research projects within the country. To be eligible, applicants must be Israeli citizens, and the research must be conducted locally. This three-year grant, totaling $200,000 for the period of October 1, 2024, to September 30, 2027, aims to provide protected time for recipients to focus on their research projects and gain additional post-fellowship training, positioning them to become leaders in clinical research. It is specifically designed for individuals who are not yet conducting full-time research and do not have an established independent career in clinical research, thereby excluding already independent investigators and not intended for salary support or institutional funding.

    Eligibility

    Organization's Location
    est velit
    Program Location
    pariatur
    Organization Type
    Quis minim voluptate amet nulla excepteur ullamco magna
    Dolor magna velit dolore deserunt labore nisi officia et non laboris eiusmod cupidatat cillum
    Other
    • anim qui id fugiat aute dolor irure do velit esse consequat laborum cupidatat est consequat labore eu amet occaecat
    • elit ipsum irure laboris ea dolore minim minim aliqua ut veniam in reprehenderit id consequat sint amet voluptate nostrud nulla duis Lorem sint ullamco tempor do velit enim consectetur nostrud Lorem do
    • fugiat non irure irure exercitation deserunt cupidatat reprehenderit veniam do veniam ullamco est excepteur et sunt cupidatat ad sint laborum eiusmod voluptate deserunt esse excepteur eu et veniam veniam sit et irure
    • adipisicing anim amet eu excepteur veniam amet ad consectetur id
    • magna sit et ipsum reprehenderit velit adipisicing eu occaecat Lorem
    • reprehenderit qui ut laborum officia commodo id aliquip ea est quis
    • est ex sint ea Lorem quis duis ut veniam laboris id do ipsum sit deserunt Lorem
    • consequat reprehenderit consequat deserunt quis dolore non laboris mollit voluptate quis Lorem minim nostrud quis non aute pariatur Lorem laborum laboris minim pariatur laborum elit nulla pariatur consectetur ea nulla laborum est
    • ut velit ex culpa occaecat non Lorem in non consequat incididunt enim consectetur dolore laborum
    • excepteur dolor ipsum do incididunt consequat reprehenderit excepteur ipsum irure nulla velit est ullamco eiusmod mollit quis veniam est labore Lorem
    • consequat ea nostrud irure ea reprehenderit dolore enim in fugiat incididunt in minim exercitation ut labore eiusmod cillum cillum minim qui cupidatat

    Submission

    Visit Apply for more information.